The drug LOY-001, which could extend the lifespan of larger dogs, cleared its first major regulatory hurdle after the FDA found a "reasonable expectation of effectiveness," according to Axios. The San Francisco-based biotech company Loyal for Dogs aims to add at least a year to the lifespans of larger dogs with the long-acting drug, administered every three to six months. Larger dogs typically live between eight and 12 years, while smaller breeds often live much longer.
Rick Good spent ten years in the newspaper business, including with The News & Observer (Raleigh, NC) and The Greenville News (Greenville, SC). He co-wrote, with Melinda Coleman, Rutledge to Riley: Governors of South Carolina, 1776–Present (Published by The Greenville News), and is the author of Mind Games Trivia #1 (Amazon). He has recently spent 15 years creating original trivia content through Sounds Good Mobile Entertainment and continues that with his new company, SGME Software. He edits The Smart Reader’s money, real estate, and business coverage.
